These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37395140)

  • 1. Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study.
    Lähteenvuo M; Paljärvi T; Tanskanen A; Taipale H; Tiihonen J
    Br J Psychiatry; 2023 Oct; 223(4):456-464. PubMed ID: 37395140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
    Lähteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J
    JAMA Psychiatry; 2018 Apr; 75(4):347-355. PubMed ID: 29490359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder.
    Holm M; Tanskanen A; Lähteenvuo M; Tiihonen J; Taipale H
    Eur Neuropsychopharmacol; 2022 Aug; 61():36-42. PubMed ID: 35763976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment of psychotic depression. Evidence from within-subject analyses of two nationwide cohorts.
    Taipale H; Lieslehto J; Lähteenvuo M; Hamina A; Tanskanen A; Mittendorfer-Rutz E; Paljärvi T; Solmi M; Cipriani A; Correll CU; Tiihonen J
    World Psychiatry; 2024 Jun; 23(2):276-284. PubMed ID: 38727044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium for acute mania.
    McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients.
    Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
    JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.
    Tiihonen J; Tanskanen A; Hoti F; Vattulainen P; Taipale H; Mehtälä J; Lähteenvuo M
    Lancet Psychiatry; 2017 Jul; 4(7):547-553. PubMed ID: 28578901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.
    Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H
    Schizophr Bull; 2022 Jan; 48(1):166-175. PubMed ID: 34286338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study.
    Kessing LV; Hellmund G; Geddes JR; Goodwin GM; Andersen PK
    Br J Psychiatry; 2011 Jul; 199(1):57-63. PubMed ID: 21593515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.
    Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
    JAMA Psychiatry; 2017 Jul; 74(7):686-693. PubMed ID: 28593216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
    Guille C; Sachs GS; Ghaemi SN
    J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy vs. combination therapy for post mania maintenance treatment: A population based cohort study.
    Wingård L; Brandt L; Bodén R; Kieler H; Andersen M; Reutfors J
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):691-700. PubMed ID: 31078359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive comparison of monotherapies for psychiatric hospitalization risk in bipolar disorders.
    Nestsiarovich A; Mazurie AJ; Hurwitz NG; Kerner B; Nelson SJ; Crisanti AS; Tohen M; Krall RL; Perkins DJ; Lambert CG
    Bipolar Disord; 2018 Dec; 20(8):761-771. PubMed ID: 29920885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of pharmacological treatment of bipolar patients discharged from psychiatric units in Poland.
    Jaracz J; Rudnicka ET; Bierejszyk M; Witczyk K; Raczyńska A; Nowak W; Pisarczyk A; Woźniak K; Czernaś W; Moniakowski A; Jaracz K
    Pharmacol Rep; 2018 Aug; 70(4):694-698. PubMed ID: 29933206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.